References
- European Medicines Agency. Vaxzevria. European public assessment report [Internet]. [cited 2021 Jun 15]. Available from: https://www.ema.europa.eu/en/documents/overview/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-medicine-overview_en.pdf.
- Chen RT, Rastogi SC, Mullen JR, et al. The vaccine adverse event reporting system (VAERS). Vaccine. 1994;12(6):542–550.
- Food and drug administration adverse event reporting system (FAERS). [cited 2021 Jun 15]. Available from: https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-latest-quarterly-data-files
- European Medicines Agency. Screening for adverse reactions in EudraVigilance. EMA/849944/2016. 2016 [cited 2021 Apr 16]:3–33. Available from: https://www.ema.europa.eu/en/documents/other/screening-adverse-reactions-eudravigilance_en.pdf
- Heinemann LA, Dinger J. Safety of a new oral contraceptive containing drospirenone. Drug Saf. 2004;27(13):1001–1018. PMID: 15471507.